Haustein K O
Institute of Clinical Pharmacology, Medical Academy Erfurt, GDR.
Int J Clin Pharmacol Ther Toxicol. 1990 Jul;28(7):273-81.
The therapeutic concepts of congestive heart failure (CHF) are based on an increase in myocardial contractility and a decrease in pre- and afterload. Besides the digitalis glycosides, diuretics and vasodilators such as nitrates, hydralazine, ACE-inhibitors, calcium antagonists or prazosine are used. Furthermore, the so-called inodilators such as phosphodiesterase III inhibitors (amrinone, milrinone), dopaminergic and beta-adrenergic receptor agonists were introduced into therapy. The boone and bane of the different classes of drugs were discussed with respect to their hemodynamic and clinical properties.
充血性心力衰竭(CHF)的治疗理念基于心肌收缩力的增强以及前负荷和后负荷的降低。除洋地黄苷外,还使用利尿剂和血管扩张剂,如硝酸盐、肼屈嗪、血管紧张素转换酶抑制剂、钙拮抗剂或哌唑嗪。此外,所谓的强心扩血管药,如磷酸二酯酶III抑制剂(氨力农、米力农)、多巴胺能和β-肾上腺素能受体激动剂也被引入治疗。针对不同类药物的血流动力学和临床特性,讨论了它们的利弊。